Q4 2015 13F Holders as of 31 Dec 2015
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
44.8M
-
Number of holders
-
379
-
Total 13F shares, excl. options
-
51M
-
Shares change
-
-456K
-
Total reported value, excl. options
-
$7.99B
-
Value change
-
+$6.72M
-
Put/Call ratio
-
0.48
-
Number of buys
-
207
-
Number of sells
-
-167
-
Price
-
$156.61
Significant Holders of UNITED THERAPEUTICS Corp - Common Stock (UTHR) as of Q4 2015
448 filings reported holding UTHR - UNITED THERAPEUTICS Corp - Common Stock as of Q4 2015.
UNITED THERAPEUTICS Corp - Common Stock (UTHR) has 379 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 51M shares
.
Largest 10 shareholders include FMR LLC (4.41M shares), VANGUARD GROUP INC (3.36M shares), SCOPIA CAPITAL MANAGEMENT LP (2.85M shares), BlackRock Fund Advisors (2.12M shares), AQR CAPITAL MANAGEMENT LLC (1.79M shares), DEUTSCHE BANK AG\ (1.76M shares), STATE STREET CORP (1.74M shares), BlackRock Institutional Trust Company, N.A. (1.66M shares), Palo Alto Investors, LLC (1.52M shares), and AJO, LP (1.48M shares).
This table shows the top 379 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.